FDA, EMEA Launch Clinical Trial Oversight Program
The U.S. Food and Drug Administration and the European Medicines Agency have launched a joint initiative to ensure the use of safe and effective practices in clinical trials as part of...To view the full article, register now.
Already a subscriber? Click here to view full article